Polyamines: New Hope Against Deadly Short QT Arrhythmias

Researchers report a pioneering approach using polyamines to counter dangerous Short QT Syndrome type 3 (SQTS3), a genetic condition that can trigger sudden cardiac events. The study, published in Nature Communications, identifies polyamines as potent modulators capable of normalizing the heart's electrical activity by tuning the defective sodium channel kinetics associated with SQTS3. SQTS3 shortens the repolarization phase, elevating risks of syncope, atrial fibrillation, ventricular tachycardia, and sudden death. Mutations affecting the SCN5A sodium channel's late current push the myocardium toward rapid repolarization, compromising rhythm stability.